Outlook 2022 – Washington, D.C. Updates and Insights on Life Sciences
On Thursday, February 10th, Ropes & Gray hosted a webinar on regulatory, compliance and enforcement changes emanating from DC and the potential impact on life sciences pharmaceutical, biotech and medical device companies in 2022. Click here to view our discussion or read the transcript.
The program examined various issues, including:
- FDA Leadership Changes, Policy Priorities, and Related Legislation
- Device Reimbursement and Drug Pricing Updates
- Anticipated Shifts in Enforcement Priorities